SMMT250117C00006000 Option on Summit Therapeutics PLC

SMMT Stock  USD 17.87  0.90  4.79%   

Summit Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Summit Total Stockholder Equity

Total Stockholder Equity

39.57 Million

At this time, Summit Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year.

Summit Therapeutics Corporate Management

Elaine JDHead CounselProfile
Fong ClowChief OfficerProfile
Betty ChangOncology ResearchProfile
Bhaskar AnandChief FinanceProfile
Will BlackHead TechnologyProfile

Additional Tools for Summit Stock Analysis

When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.